DBVT (DBV Tech) Market Value to Book Value Ratio
The market price for DBV Technologies S.A. (DBVT) on GURU.Markets, which stands at 3.68 as confirmed by the chart, accompanies the operations of research centers in the US and France dedicated to creating unique transdermal systems. Current monetization is limited to the testing phase; therefore, future profits will depend on the terms set by US insurers. The business is based on the breakthrough Viaskin technology, aimed at combating severe forms of food allergies.
%3A%20Market%20Capitalization%20to%20Net%20Assets&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_DBVT_-_DBV-Technologies-S.A._-_Market-Capitalization-to-Net-Assets "DBVT DBV Technologies Market Capitalization to Book Value Ratio (07/04/2022 - 10/27/2026) | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for DBV Technologies S.A. (DBVT)
The stability of DBV Technologies S.A. (DBVT) is based on strict adherence to biopharmaceutical standards during the development of anti-allergen patches. Analyzing this chart of the market capitalization to net asset ratio, an investor can see the gap between the exchange valuation and the actual value of assets, which allows for determining the degree of overpayment for the company relative to its actual book value.